Modern approach to the diagnosis and treatment of tuberculosis in children (Q39643310)

13 September 2017

1 reference

title

Modern approach to the diagnosis and treatment of tuberculosis in children (English)

1 reference

13 September 2017

0 references

Starke JR

1

1 reference

13 September 2017

1 June 1988

1 reference

Pediatric Clinics of North America

13 September 2017

1 reference

13 September 2017

35

1 reference

13 September 2017

3

1 reference

13 September 2017

441-464

1 reference

Methods of improving patient compliance in chronic disease states

13 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Mycobacterial cervical lymphadenopathy: 1981 update

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Short-course therapy for tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Parent Reading and Reporting of Children's Tuberculin Skin Test Results

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

The influence of epidemiologic factors on drug resistance rates in tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Selective procedures for detecting femtomole quantities of tuberculostearic acid in serum and cerebrospinal fluid by frequency-pulsed electron capture gas-liquid chromatography.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Toxic effects of isoniazid in tuberculosis chemoprophylaxis. Role of biochemical monitoring in 1,000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Protective value of BCG vaccination in children in Bangkok, Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Endobronchial tuberculosis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Enzyme-linked immunosorbent assay using Mycobacterium tuberculosis antigen 5 and PPD for the serodiagnosis of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Bactericidal Activity of Streptomycin, Isoniazid, Rifampin, Ethambutol, and Pyrazinamide Alone and In Combination Against Mycobacterium Tuberculosis1

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Mycobacterium tuberculosis infection in the acquired immunodeficiency syndrome. A review of 14 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Short-course treatment regimens for patients with tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Present chemotherapy for tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Short-course Chemotherapy for Tuberculosis with Largely Twice-weekly Isoniazid-Rifampin

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Undesirable side effects of isoniazid and rifampin in largely twice-weekly short-course chemotherapy for tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Short-course chemotherapy for tuberculosis with mainly twice-weekly isoniazid and rifampin. Community physicians' seven-year experience with mainly outpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis: final report. East and Central African/British Medical Research Council Fifth Collaborative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Whither short-course chemotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Diagnosis of pulmonary tuberculosis by detection of tuberculostearic acid in sputum by using gas chromatography-mass spectrometry with selected ion monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Enzyme immunoassay using BCG in serodiagnosis of pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

From the Centers for Disease Control. Conference on new approaches for tuberculosis preventive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

The role of pyrazinamide in primary chemotherapy for pulmonary tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Ethambutol MICs and MBCs for Mycobacterium avium complex and Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Transfer of tuberculin immunity from mother to infant

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Choice of preventive treatment for isoniazid-resistant tuberculous infection. Use of decision analysis and the Delphi technique

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Depression of parahydroxylation of diphenylhydantoin by antituberculosis chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Determination of minimal inhibitory concentrations of antituberculosis drugs by radiometric and conventional methods

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Isoniazid hepatitis in adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Isoniazid-resistant tuberculosis. A community outbreak and report of a rifampin prophylaxis failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Interobserver and method variability in tuberculin skin testing

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Treatment of tuberculosis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Clinical experience with short-course chemotherapy in patients with tubercular pleural effusion and lymphadenitis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Chronic lymphadenopathy due to mycobacterial infection. Clinical features, diagnosis, histopathology, and management.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Bullous emphysema in childhood tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Clinical importance of the interaction of phenytoin and isoniazid: a report from the Boston Collaborative Drug Surveillance Program

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

The action of antituberculosis drugs in short-course chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Natural history of segmental lesions in primary pulmonary tuberculosis: long-term review of 383 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

High rate of tuberculin conversion in Indochinese refugees

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

New responsibilities for health departments and public health nurses in tuberculosis-- keeping the outpatient on therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Exogenous reinfection with tuberculosis in a shelter for the homeless.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Childhood tuberculosis in North Carolina: a study of the opportunities for intervention in the transmission of tuberculosis to children

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Pyridoxine deficiency in children treated with isoniazid

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Tuberculin skin test reactivity and conversions in United States- and foreign-born Latino children.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Tuberculosis among Indochinese refugees in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Clinical Pharmacology of Antitubercular Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Whole chromosomal DNA probes for rapid identification of Mycobacterium tuberculosis and Mycobacterium avium complex

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

The age threshold for isoniazid chemoprophylaxis. A decision analysis for low-risk tuberculin reactors

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Activity of amikacin against Mycobacteria in vitro and in murine tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Compliance: Inducements and Enforcements

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Miliary tuberculosis in children. Clinical and laboratory manifestation in 19 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

What about short course and intermittent chemotherapy for tuberculosis in children?

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Preventive therapy with isoniazid. Cost-effectiveness of different durations of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Primary drug-resistant tuberculosis in children. Correlation of drug-susceptibility patterns of matched patient and source case strains of Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Persistently negative tuberculin reactions: their presence among children with culture positive for Mycobacterium tuberculosis (tuberculin-negative tuberculosis).

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

A continuing study of primary drug-resistant tuberculosis among children observed at the Kings County Hospital Medical Center between the years 1961 and 1980.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

A controlled trial of six-month and nine-month regimens of chemotherapy in patients undergoing radical surgery for tuberculosis of the spine in Hong Kong. Tenth report of the Medical Research Council Working Party on Tuberculosis of the Spine

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Evaluation of a radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Extrapulmonary tuberculosis. Experience of a community hospital and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

Antituberculous drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936465-3

7 January 2021

10.1016/S0031-3955(16)36465-3

Identifiers

DOI

0 references

PubMed ID

3287309

1 reference

PubMed ID

3287309